Clarence E Grim1, Carlene M Grim. 1. Medical College of Wisconsin, Milwaukee, Wisconsin 53211, USA. lowerbp2@mac.com
Abstract
OBJECTIVE: To test the accuracy of the Omron Elite 7300W home blood pressure monitor using the European Society of Hypertension (ESH) Protocol. METHODS: The device was tested using the European Society of Hypertension International Protocol in 33 women and then in 10 men to satisfy the ESH for both men and women. RESULTS: The average error in all participants was 1.2+/-5.2 (SD) [(range -10 to 17)/3.29+/-5.5 (-6 to 17)] mmHg. This is the first device to have been tested using the ESH protocol for the special population of women only. The additional testing of men in the standard ESH protocol enables the validation of this device specifically in women but also in men. However, as with all automatic devices, it is important to validate its accuracy in each individual patient who uses it and to monitor its accuracy intermittently in each individual patient. CONCLUSION: The Omron Elite 7300W home blood pressure monitor passed the ESH validation protocol and can be recommended for patient use.
OBJECTIVE: To test the accuracy of the Omron Elite 7300W home blood pressure monitor using the European Society of Hypertension (ESH) Protocol. METHODS: The device was tested using the European Society of Hypertension International Protocol in 33 women and then in 10 men to satisfy the ESH for both men and women. RESULTS: The average error in all participants was 1.2+/-5.2 (SD) [(range -10 to 17)/3.29+/-5.5 (-6 to 17)] mmHg. This is the first device to have been tested using the ESH protocol for the special population of women only. The additional testing of men in the standard ESH protocol enables the validation of this device specifically in women but also in men. However, as with all automatic devices, it is important to validate its accuracy in each individual patient who uses it and to monitor its accuracy intermittently in each individual patient. CONCLUSION: The Omron Elite 7300W home blood pressure monitor passed the ESH validation protocol and can be recommended for patient use.
Authors: Liang Feng; Imtiaz Jehan; H Asita de Silva; Aliya Naheed; Aamir H Khan; Anuradhani Kasturiratne; John D Clemens; Ching Wee Lim; Alun D Hughes; Nish Chaturvedi; Tazeen H Jafar Journal: Am J Hypertens Date: 2021-09-22 Impact factor: 2.689